Settlement Reached Over Cancer Test Patents

Law360, New York (January 8, 2007, 12:00 AM EST) -- Medical testing company PreMD Inc. has entered into a licensing agreement with an inventor, thus resolving a long-running dispute over patents related to tests for detecting breast, lung and colorectal cancer.

The Toronto-based company, which manufactures tests for detecting life-threatening illnesses, said it will retain the exclusive rights to its ColorectAlert and LungAlert tests, as well as breast cancer test technologies, as part of the agreement.

PreMD said the new agreement amended an earlier licensing agreement with the patents’ inventor, Abulkalam Shamsuddin, relating to two U.S....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.